United States (US) Fibromyalgia Market (2025-2031) | Value, Outlook, Competitive Landscape, Segmentation, Analysis, Companies, Share, Industry, Growth, Size & Revenue, Trends, Forecast

Market Forecast By Diagnosis (Blood Tests, Others), By Treatment (Medication, Therapy, Others), By Route of Administration (Oral, Parenteral, Others), By End-Users (Hospitals, Homecare, Specialty Clinics, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) And Competitive Landscape
Product Code: ETC9965882 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Vasudha No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Fibromyalgia Market Outlook
  • Market Size of United States (US) Fibromyalgia Market, 2024
  • Forecast of United States (US) Fibromyalgia Market, 2031
  • Historical Data and Forecast of United States (US) Fibromyalgia Revenues & Volume for the Period 2021- 2031
  • United States (US) Fibromyalgia Market Trend Evolution
  • United States (US) Fibromyalgia Market Drivers and Challenges
  • United States (US) Fibromyalgia Price Trends
  • United States (US) Fibromyalgia Porter's Five Forces
  • United States (US) Fibromyalgia Industry Life Cycle
  • Historical Data and Forecast of United States (US) Fibromyalgia Market Revenues & Volume By Diagnosis for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Fibromyalgia Market Revenues & Volume By Blood Tests for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Fibromyalgia Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Fibromyalgia Market Revenues & Volume By Treatment for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Fibromyalgia Market Revenues & Volume By Medication for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Fibromyalgia Market Revenues & Volume By Therapy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Fibromyalgia Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Fibromyalgia Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Fibromyalgia Market Revenues & Volume By Oral for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Fibromyalgia Market Revenues & Volume By Parenteral for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Fibromyalgia Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Fibromyalgia Market Revenues & Volume By End-Users for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Fibromyalgia Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Fibromyalgia Market Revenues & Volume By Homecare for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Fibromyalgia Market Revenues & Volume By Specialty Clinics for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Fibromyalgia Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Fibromyalgia Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Fibromyalgia Market Revenues & Volume By Hospital Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Fibromyalgia Market Revenues & Volume By Online Pharmacy for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Fibromyalgia Market Revenues & Volume By Retail Pharmacy for the Period 2021- 2031
  • United States (US) Fibromyalgia Import Export Trade Statistics
  • Market Opportunity Assessment By Diagnosis
  • Market Opportunity Assessment By Treatment
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By End-Users
  • Market Opportunity Assessment By Distribution Channel
  • United States (US) Fibromyalgia Top Companies Market Share
  • United States (US) Fibromyalgia Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Fibromyalgia Company Profiles
  • United States (US) Fibromyalgia Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United States (US) Fibromyalgia Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United States (US) Fibromyalgia Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Fibromyalgia Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Fibromyalgia Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Fibromyalgia Market - Industry Life Cycle

3.4 United States (US) Fibromyalgia Market - Porter's Five Forces

3.5 United States (US) Fibromyalgia Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F

3.6 United States (US) Fibromyalgia Market Revenues & Volume Share, By Treatment, 2021 & 2031F

3.7 United States (US) Fibromyalgia Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 United States (US) Fibromyalgia Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.9 United States (US) Fibromyalgia Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 United States (US) Fibromyalgia Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness and diagnosis rates of fibromyalgia in the US

4.2.2 Growing aging population leading to higher prevalence of fibromyalgia

4.2.3 Advancements in medical research and technology improving treatment options for fibromyalgia patients

4.3 Market Restraints

4.3.1 Lack of definitive diagnostic tests for fibromyalgia leading to misdiagnosis

4.3.2 Limited understanding of the exact cause of fibromyalgia hindering development of targeted therapies

4.3.3 High cost of treatment for fibromyalgia patients impacting accessibility to care

5 United States (US) Fibromyalgia Market Trends

6 United States (US) Fibromyalgia Market, By Types

6.1 United States (US) Fibromyalgia Market, By Diagnosis

6.1.1 Overview and Analysis

6.1.2 United States (US) Fibromyalgia Market Revenues & Volume, By Diagnosis, 2021- 2031F

6.1.3 United States (US) Fibromyalgia Market Revenues & Volume, By Blood Tests, 2021- 2031F

6.1.4 United States (US) Fibromyalgia Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Fibromyalgia Market, By Treatment

6.2.1 Overview and Analysis

6.2.2 United States (US) Fibromyalgia Market Revenues & Volume, By Medication, 2021- 2031F

6.2.3 United States (US) Fibromyalgia Market Revenues & Volume, By Therapy, 2021- 2031F

6.2.4 United States (US) Fibromyalgia Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Fibromyalgia Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 United States (US) Fibromyalgia Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 United States (US) Fibromyalgia Market Revenues & Volume, By Parenteral, 2021- 2031F

6.3.4 United States (US) Fibromyalgia Market Revenues & Volume, By Others, 2021- 2031F

6.4 United States (US) Fibromyalgia Market, By End-Users

6.4.1 Overview and Analysis

6.4.2 United States (US) Fibromyalgia Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 United States (US) Fibromyalgia Market Revenues & Volume, By Homecare, 2021- 2031F

6.4.4 United States (US) Fibromyalgia Market Revenues & Volume, By Specialty Clinics, 2021- 2031F

6.4.5 United States (US) Fibromyalgia Market Revenues & Volume, By Others, 2021- 2031F

6.5 United States (US) Fibromyalgia Market, By Distribution Channel

6.5.1 Overview and Analysis

6.5.2 United States (US) Fibromyalgia Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.5.3 United States (US) Fibromyalgia Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.5.4 United States (US) Fibromyalgia Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

7 United States (US) Fibromyalgia Market Import-Export Trade Statistics

7.1 United States (US) Fibromyalgia Market Export to Major Countries

7.2 United States (US) Fibromyalgia Market Imports from Major Countries

8 United States (US) Fibromyalgia Market Key Performance Indicators

8.1 Average time taken for diagnosis of fibromyalgia

8.2 Percentage of fibromyalgia patients using alternative therapies

8.3 Number of clinical trials focusing on fibromyalgia treatments

9 United States (US) Fibromyalgia Market - Opportunity Assessment

9.1 United States (US) Fibromyalgia Market Opportunity Assessment, By Diagnosis, 2021 & 2031F

9.2 United States (US) Fibromyalgia Market Opportunity Assessment, By Treatment, 2021 & 2031F

9.3 United States (US) Fibromyalgia Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 United States (US) Fibromyalgia Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.5 United States (US) Fibromyalgia Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 United States (US) Fibromyalgia Market - Competitive Landscape

10.1 United States (US) Fibromyalgia Market Revenue Share, By Companies, 2024

10.2 United States (US) Fibromyalgia Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here
Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Leadership Perspectives from Industry Events

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Industry Events and Analyst Meet

Whitepaper

Read All